Full Text View
Tabular View
No Study Results Posted
Related Studies
A Phase IIb Study to Determine the Efficacy and Safety of the Study Drug in Patients With Severe Sepsis
This study has been completed.
Study NCT00034476   Information provided by Eli Lilly and Company
First Received: April 29, 2002   Last Updated: July 18, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Sepsis
More general conditions related to this trial
Infection
Inflammation
Pathologic Processes
Systemic Inflammatory Response Syndrome
Interventions listed in this trial
sPLA2 Inhibitor
Sponsors listed in this trial
Eli Lilly and Company


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services